Vaccine, price control; Grievance redress in finance.
I have a column in the Business Standard today, Price controls for vaccines?, which thinks about the problem of incentives and the private health care sector, in scaling up the vaccination program.
Renuka Sane, Srishti Sharma and Karthik Suresh have an article in The Leap Blog, on 26 February, titled Grievance Redress in the Financial Sector in India: Lessons from the field.
Create your profile
Only paid subscribers can comment on this post
Check your email
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.